Infrastructure Capital Advisors LLC Boosts Stock Holdings in Kenvue Inc. $KVUE

Infrastructure Capital Advisors LLC lifted its stake in shares of Kenvue Inc. (NYSE:KVUE) by 435.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 136,259 shares of the company’s stock after acquiring an additional 110,819 shares during the quarter. Infrastructure Capital Advisors LLC’s holdings in Kenvue were worth $2,350,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of KVUE. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Kenvue during the second quarter worth $6,528,000. Jump Financial LLC increased its holdings in Kenvue by 210.6% in the second quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock valued at $1,147,000 after buying an additional 37,170 shares during the last quarter. AXA S.A. increased its holdings in Kenvue by 21.1% in the second quarter. AXA S.A. now owns 48,892 shares of the company’s stock valued at $1,023,000 after buying an additional 8,524 shares during the last quarter. NewEdge Advisors LLC increased its holdings in Kenvue by 219.1% in the second quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock valued at $2,040,000 after buying an additional 66,930 shares during the last quarter. Finally, The Manufacturers Life Insurance Company increased its holdings in Kenvue by 0.6% in the second quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock valued at $39,217,000 after buying an additional 10,885 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Kenvue Stock Performance

NYSE KVUE opened at $18.03 on Thursday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $22.87. The company has a market capitalization of $34.61 billion, a PE ratio of 21.21, a P/E/G ratio of 1.40 and a beta of 0.54. The company has a fifty day moving average of $17.49 and a two-hundred day moving average of $17.56.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The company had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. During the same quarter in the prior year, the firm posted $0.24 earnings per share. Kenvue’s revenue for the quarter was up 4.5% on a year-over-year basis. As a group, analysts expect that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a yield of 4.6%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio is currently 97.65%.

Insider Transactions at Kenvue

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.59% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms recently commented on KVUE. Barclays dropped their target price on Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 14th. Argus raised Kenvue to a “hold” rating in a report on Friday, March 6th. Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday. Zacks Research raised Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Finally, Citigroup dropped their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $19.33.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.